New leadership team appointed at lifespin, strengthening go-to-market activities and accelerating growth

Regensburg, Germany – September 16, 2025 – lifespin GmbH, a frontrunner in personalized medical analysis based on metabolomics, announces the appointment of its new leadership team. Dr. Sonja Wiedemann is joining the company as new CEO and CTO. Dr. Ali Tinazli will continue in his role as CEO and CCO. The team is completed by Dr. Roland Geyer, who was promoted to the senior management team as managing director, continuing in his role as COO.

Dr. Sonja Wiedemann comes with a strong strategy and industry background in the pharma and healthcare space as well as years of experience leading and building businesses in the laboratory services market. Her skills complement the profound knowledge on NMR spectroscopy, metabolomics, and related insights of Dr. Ali Tinazli and Dr. Roland Geyer.

“We’re excited by the strong new leadership team at lifespin. Sonja brings a lot of highly valuable experience in building and running businesses, in regulatory affairs and a deep knowledge of the European lab services landscape. She will drive the strategy and the R&D efforts towards innovative products with market fit and complements Ali, who will continue leading global commercial strategy, business development, and sales, and Roland, who will head operations.” said Robert Wieland, lead investor. “Sonja’s leadership experience and fresh perspective come at exactly the right time as lifespin continues to expand its impact and grow its business.”

“I’m thrilled to be joining lifespin at such an exciting moment,” said Dr. Wiedemann. “The company has developed an amazing foundation, ready to fuel a range of innovative products. I look forward to working with the team to bring these solutions to the market, leading the way to a proactive approach to health management.”

About lifespin GmbH: Lifespin GmbH, headquartered in Regensburg, Germany, is a pioneer in NMR-based metabolomics, delivering innovative software solutions for proactive health assessment. With a robust database of over 275,000 metabolomic profiles and a commitment to data-driven innovation, lifespin is shaping the future of personalized healthcare globally. For more information, visit www.lifespin.health.

Media Contact lifespin GmbH Email: info@lifespin.health Phone: +49 941/942 898 0

More from press and media

Scroll to Top
video-thumb

Dr. Roland Geyer

COO
10+ years experience in NMR-based metabolomics and diagnostic.

Dr. Renate Kirchhöfer

CDO & Co-Founder
20+ years developing NMR-applications and bringing them to regulated markets.

Dr. Fritz Huber

CEO & Co-Founder
20+ years developing and marketing NMR-based assays—he is a pioneer in this field.

Dr. Ali Tinazli

CEO, lifespin GmbH

15+ years in Fortune 100 corporate strategy and entrepreneurship (SONY, HP).